Portrait of Kennedy, John N

Kennedy, John N

U.S. Senator LA Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
7
Buys / sells
57% / 0%
Last trade
Apr 21, 2025
Last filing
May 8, 2025

Latest disclosed trades

Latest 7 of 7
Ticker Type Traded
NLY Buy Apr 21, 2025
Annaly Capital Management Inc Buy Apr 21, 2025
MTUM Buy Oct 11, 2018
iShares Edge MSCI USA Momentum F Buy Oct 11, 2018
CVG (Exchanged) Exchange Oct 9, 2018
CVG (Exchanged) Exchange Oct 9, 2018
CVG (Exchanged) Exchange Oct 9, 2018

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Kennedy, John N stock trade activity

FilingIQ has indexed 7 congressional stock trade disclosures for Kennedy, John N. The most recent disclosed transaction is dated Apr 21, 2025.

Across the full history, 4 purchases and 0 sales have been disclosed under the STOCK Act.

Top tickers traded by Kennedy, John N

Frequently asked

How many stock trades has Kennedy, John N disclosed?
FilingIQ tracks 7 Periodic Transaction Report disclosures for Kennedy, John N, with the most recent dated Apr 21, 2025. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Kennedy, John N a net buyer or net seller?
Across the disclosed trade history, 4 (57%) were purchases and 0 (0%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Kennedy, John N come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.